Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization

详细信息    查看全文

• 作者：Kimberly J. Hassett ; Megan C. Cousins ; Lilia A. Rabia ; Chrystal M. Chadwick ; Joanne M. O¡¯Hara ; Pradyot N ; i ; Robert N. Brey ; Nicholas J. Mantis ; John F. Carpenter ; Theodore W. R ; olph
• 关键词：Lyophilization ; Freeze drying ; Aluminum ; Adjuvant ; Stability ; Biodefense ; Aggregation ; Ricin ; Vaccine
• 刊名：European Journal of Pharmaceutics and Biopharmaceutics
• 出版年：2013
• 出版时间：October, 2013
• 年：2013
• 卷：85
• 期：2
• 页码：279-286
• 全文大小：1266 K

文摘

Lyophilization was used to prepare dry, glassy solid vaccine formulations of recombinant ricin toxin A-chain containing suspensions of colloidal aluminum hydroxide adjuvant. Four lyophilized formulations were prepared by using combinations of rapid or slow cooling during lyophilization and one of two buffers, histidine or ammonium acetate. Trehalose was used as the stabilizing excipient. Aggregation of the colloidal aluminum hydroxide suspension was reduced in formulations processed with a rapid cooling rate. Aluminum hydroxide particle size distributions, glass transition temperatures, water contents, and immunogenicities of lyophilized vaccines were independent of incubation time at 40 ¡ãC for up to 15 weeks. Mice immunized with reconstituted ricin toxin subunit A (RTA) vaccines produced RTA-specific antibodies and toxin-neutralizing antibodies (TNAs) regardless of the length of high temperature vaccine storage or the degree of aluminum adjuvant aggregation that occurred during lyophilization. In murine studies, lyophilized formulations of vaccines conferred protection against exposure to lethal doses of ricin, even after the lyophilized formulations had been stored at 40 ¡ãC for 4 weeks. A corresponding liquid formulation of vaccine stored at 40 ¡ãC elicited RTA-specific antibody titers but failed to confer immunity during a ricin challenge.